Frazier Life Sciences Public Fund, L.P. 13D/13G Filings for Xilio Therapeutics, Inc. (XLO)

Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
1:47 pm
Purchase
2025-06-3013GXilio Therapeutics, Inc.
XLO
Frazier Life Sciences Public Fund, L.P. 8,141,017
9.900%
2,393,824increase
(+41.65%)
Filing
2025-06-12
4:55 pm
Purchase
2025-06-0513GXilio Therapeutics, Inc.
XLO
Frazier Life Sciences Public Fund, L.P. 5,747,193
9.900%
5,747,193increase
(New Position)
Filing